¿Can a Mobile App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus? Clinical Evaluation of mySugr App
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03819335|
Recruitment Status : Recruiting
First Posted : January 28, 2019
Last Update Posted : April 11, 2019
This project is based on the contribution that an app can offer for improving knowledge and self-management of people with type 1 diabetes.
The main objective of this study is to assess mySugr app as a tool for empowering people with type 1 diabetes.
The study population are type 1 diabetes people, aged more than 18 years old and with more than one year from diagnosis. They will be randomised to standard care or use of mySugr app and will be followed-up during 48 weeks.
Control group will attend 5 face-to-face visits (baseline, 3, 6, 9 and 12 months) with the possibility of telephone contact and hospital assistance if necessary. Intervention group will attend 3 face-to-face visits (baseline, 6 and 12 months) and 2 telematic visits (at 3 and 9 months) and will also have the possibility of telephone contact and hospital assistance if necessary.
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus, Type 1||Device: mySugr app Other: Standard care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||¿Puede Una aplicación móvil Mejorar el Conocimiento y la autogestión de Las Personas Con Diabetes Tipo 1? Evaluación clínica de la App mySugr|
|Actual Study Start Date :||April 9, 2019|
|Estimated Primary Completion Date :||May 2020|
|Estimated Study Completion Date :||September 2020|
Active Comparator: Standard care
Usual follow-up of diabetes type 1 with face-to-face visits
Other: Standard care
Experimental: mySugr app
Telemedical assistance with mySugr app
Device: mySugr app
mySugr is a mobile medical app for diabetes management. It has been developed by Roche Diabetes Care and it has two versions, free and Pro. It allows to carry out the diary of diabetes, including the collection and analysis of data on glycaemia, food, physical activity or insulin dose. In addition, it is compatible with continuous glucose measurement systems. It has the possibility to add functionalities such as estimation of HbA1c levels, more detailed data analysis or integration with Google Fit type motion sensors, as well as a bolus calculator, reminders for measuring blood glucose or photo gallery in the Pro version, which is the one that will be provided to the patients for the study.
- Empowerment [ Time Frame: Baseline visit and month 12 ]Change from baseline score in the Diabetes Empowerment Scale-Short Form Spanish version (DES-SF-S) (8, worse to 40, better) at 12 months
- Adherence to glycemic monitoring [ Time Frame: Baseline visit and month 3, 6, 9 and 12 ]Change from baseline frequency of glycemic monitoring (number of capillary blood glucose tests per day) at each follow-up visit
- Adherence to recommendations [ Time Frame: Each follow-up visit (month 3, 6, 9 and 12) ]Percentage of recommendations given by the medical team followed
- Adherence to visits [ Time Frame: Each follow-up visit (month 3, 6, 9 and 12) ]Percentage of face-to-face visits and telematic visits attended
- Adherence to the app [ Time Frame: End of the study (month 12) and 3 months after ]Percentage of patients who continue using the app after the end of the study
- Daily management of diabetes [ Time Frame: Baseline visit and month 12 ]Change from baseline score in the questionnaire that evaluates the number of tasks performed in relation to diabetes (ad hoc) at 12 months
- Quality of life related to diabetes [ Time Frame: Baseline visit and month 12 ]Change from baseline score in the Spanish version of the Diabetes Quality Of Life questionnaire (EsDQOL) (satisfaction: 75, worse, to 15, better; impact: 85, worse, to 17, better; social and vocational concern: 45, worse, to 7, better; concern related to diabetes: 20, worse, to 4, better) at 12 months
- Self-efficacy [ Time Frame: Baseline visit and month 12 ]Change from baseline score in the Diabetes Distress Scale Spanish version (DSS-S) (102, worse, to 17, better) at 12 months
- Glycemic control [ Time Frame: Baseline visit and month 3, 6, 9 and 12 ]Change from baseline mean blood glucose (mg/dl), standard deviation, low and high blood glucose index at each follow-up visit
- Glycemic control [ Time Frame: Baseline visit and month 6 and 12 ]Change from baseline HbA1c DCA (%) at 6 and 12 months
- Satisfaction with the app [ Time Frame: End of the study (month 12) ]Score in the satisfaction questionnaire in relation to the use of the platform (ad hoc)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03819335
|Contact: Cintia González Blanco, MD, PhDemail@example.com|
|Hospital de la Santa Creu i Sant Pau||Recruiting|
|Barcelona, Spain, 08025|
|Contact: Cintia Gonzalez Blanco, MD, PhD +34610898918 firstname.lastname@example.org|
|Principal Investigator: Cintia Gonzalez Blanco, MD, PhD|
|Sub-Investigator: Gemma Cuixart Carruesco, MD|